Vericel Corp. Stock
Price
Target price
?
?
1.470%
0.4
1.470%
-
07:34 / Stuttgart Stock Exchange
WKN: A12FU4 / Symbol: ASTM / Name: Vericel / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Vericel Corp. Stock
There is an upward development for Vericel Corp. compared to yesterday, with an increase of €0.40 (1.470%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Vericel Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Vericel Corp. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vericel Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vericel Corp. | 1.470% | 6.250% | -6.207% | -30.964% | -50.092% | 15.893% | 59.718% |
| Pacira Pharmaceuticals | 0.970% | -3.704% | -6.306% | 42.466% | 12.432% | -62.523% | -58.065% |
| Rockwell Medical Inc. | -0.100% | -4.815% | -26.624% | -68.447% | -49.008% | -21.527% | -89.730% |
| Twist Bioscience Corp | 1.130% | 15.455% | 20.600% | -32.878% | -42.007% | -31.869% | -62.114% |
Comments
News
Vericel Q2 Revenue Jumps 20%
Vericel (NASDAQ:VCEL), a cell therapy specialist focused on sports medicine and burn care, reported its Q2 2025 results on July 31, 2025. The most headline-worthy news was the 20% year-over-year
